Start Submission Become a Reviewer

Reading: New-onset diabetes in COVID-19: A literature review

Download

A- A+
Alt. Display

Review Articles

New-onset diabetes in COVID-19: A literature review

Authors:

N. P. Nugroho ,

Universitas Airlangga, ID
About N. P.
Department of Pulmonology & Respiratory Medicine, Faculty of Medicine


Dr Soetomo General Teaching Hospital, Indonesia
X close

H. Novida,

Universitas Airlangga, ID
About H.

Department of Internal Medicine, Faculty of Medicine

Dr Soetomo General Teaching Hospital, Indonesia

X close

S. P. Hapsari

Simpang Lima Gumul Hospital, Kediri, ID
About S. P.
Emergency Department
X close

Abstract

COVID-19 has become a major global health problem. COVID-19 teaches us many things, one of which is the relationship between COVID-19 and diabetes. Recent evidence suggests that the coronavirus may cause diabetes. In addition, the term new-onset diabetes in COVID-19 was introduced in 2020, and evidence has been reported. It poses a new challenge to the clinical management of COVID-19 patients. The pathophysiology of this disease is still not fully known. However, hypotheses have been proposed. Therefore, we write this literature review to add insight into new-on set diabetes in COVID-19 patients.
How to Cite: Nugroho, N.P., Novida, H. and Hapsari, S.P., 2022. New-onset diabetes in COVID-19: A literature review. Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 12(1), pp.31–39. DOI: http://doi.org/10.4038/sjdem.v12i1.7449
Published on 28 Jun 2022.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus